Free shipping on all orders over $ 500

Ranolazine dihydrochloride

Cat. No. M3956
Ranolazine dihydrochloride Structure
Synonym:

RS 43285

Size Price Availability Quantity
10mM*1mL in DMSO USD 75  USD75 In stock
100mg USD 65  USD65 In stock
500mg USD 175  USD175 In stock
1g USD 220  USD220 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ranolazine (CVT 303) is an anti-angina and anti-ischemia agent that works by inhibiting the late effects of inward sodium current (IC50 values of 6 μM and 12 μM for INa and IKr, respectively) without affecting heart rate or blood pressure. Ranolazine is also a partial inhibitor of fatty acid oxidation (FAO).

Chemical Information
Molecular Weight 500.46
Formula C24H35Cl2N3O4
CAS Number 95635-56-6
Form Solid
Solubility (25°C) DMSO 100mg/ml
water 100mg/ml
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Belardinelli L, et al. Heart. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

[2] Undrovinas AI, et al. J Cardiovasc Electrophysiol. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.

[3] McCormack JG, et al. Circulation. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts.

[4] Allely MC, et al. Br J Pharmacol. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion.

Related Calcium Channel Products
ω-Agatoxin TK

ω-Agatoxin TK, a peptidyl toxin of the venom of Agelenopsis aperta, is a potent and selective P/Q type Ca2+ channel blocker.

SNX-482

SNX-482, a peptidyl toxin of the spider Hysterocrates gigas, is a potent, high affinity, selective and voltage-dependent R-type CaV2.3 channel blocker with an IC50 of 30 nM.

ω-Conotoxin MVIIC

ω-Conotoxin MVIIC is a N- and P/Q-type Ca2+ channel blocker, significantly suppresses the 11-keto-βboswellic acid-mediated inhibition of glutamate release.

ω-Conotoxin GVIA

ω-Conotoxin GVIA is an inhibitor of the N-type Ca2+ channel.

ω-Conotoxin CnVIIA

ω-Conotoxin CnVIIA, a 27 amino acid neuropeptide toxin, is a N-type calcium current blocker.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ranolazine dihydrochloride, RS 43285 supplier, Calcium Channel, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.